GROUP ONE TRADING, L.P. - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2022$369,593
+451.6%
6,984
+381.7%
0.00%
Q3 2022$67,000
-86.6%
1,450
-84.8%
0.00%
Q4 2021$499,000
-51.6%
9,541
-65.5%
0.00%
-100.0%
Q3 2021$1,030,000
+114.1%
27,628
+134.3%
0.00%0.0%
Q2 2021$481,000
+1.5%
11,794
-15.7%
0.00%0.0%
Q1 2021$474,000
+14.5%
13,984
-13.3%
0.00%0.0%
Q3 2020$414,000
-77.7%
16,132
-77.7%
0.00%
-88.9%
Q2 2020$1,857,000
+366.6%
72,353
+35.9%
0.01%
+200.0%
Q3 2019$398,000
+78.5%
53,244
+172.2%
0.00%
+50.0%
Q4 2018$223,000
-80.8%
19,561
-63.5%
0.00%
-77.8%
Q3 2018$1,162,000
-4.3%
53,541
-22.0%
0.01%
-10.0%
Q2 2018$1,214,000
-22.8%
68,686
-8.0%
0.01%
-37.5%
Q1 2018$1,572,000
+86.7%
74,681
+28.4%
0.02%
+166.7%
Q4 2017$842,000
+40.1%
58,182
+52.8%
0.01%
+20.0%
Q3 2017$601,000
+251.5%
38,086
+176.6%
0.01%
+150.0%
Q2 2017$171,000
+144.3%
13,770
+219.3%
0.00%
+100.0%
Q1 2017$70,000
-4.1%
4,312
-10.8%
0.00%0.0%
Q4 2016$73,000
-25.5%
4,835
-25.0%
0.00%0.0%
Q3 2016$98,000
-79.9%
6,446
-63.2%
0.00%
-85.7%
Q1 2016$487,000
-33.1%
17,534
+29.6%
0.01%
-22.2%
Q4 2015$728,000
+48.0%
13,533
+10.1%
0.01%
+28.6%
Q3 2015$492,000
+80.2%
12,291
+44.1%
0.01%
+75.0%
Q2 2015$273,0008,5310.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders